中药内服外敷治疗强直性脊柱炎的临床分析

Clinical efficacy of TCM medicine on ankylosing spondylitis

目的:探究中药内服外敷治疗强直性脊柱炎的临床效果。方法:选取2017年1月-2019年3月我院收治的强直性脊柱炎患者64例,随机分为联合组与参照组,参照组实施中医内治治疗,对于湿热瘀阻患者给予清热强脊加减汤治疗,对于肾虚瘀阻患者给予补肾强脊加减汤治疗;联合组实施中药内服外敷治法,在参照组治疗基础上,实施中医穴位敷贴治法。对比两组患者治疗总有效率,采用Bath强直性脊柱炎测量指数(Bath Ankylosing Spondylitis Metrology Index,BASMI)评估各项指标改善状况,采用健康评定量表(HAQ)评估治疗后患者生活质量改善情况。结果:两组治疗总有效率比较:联合组治疗总有效率为87.5%,参照组治疗总有效率为62.5%,联合组明显高于参照组,差异有统计学意义,P <0.05;两组BASMI指标改善状况比较:两组患者腰椎前屈与腰椎侧弯改善方面差异无统计学意义,P> 0.05,联合组BASMI其他指标改善情况明显高于参照组,差异有统计学意义,P <0.05;两组生活治疗改善情况比较:经治疗后,两组患者生活质量评分均有所改善,联合组改善情况高于参照组,差异有统计学意义,P <0.05。结论:对于强直性脊柱炎患者而言,实施中药内服外敷治法效果高于中医内治法,其有利于改善胸背、颈椎疼痛症状,促进患者生活质量及活动能力提升,效果显著,具有较高的临床应用及推广价值。

Objective: To explore efficacy of TCM medicine on ankylosing spondylitis. Methods: 64 patients were randomly divided into the combined group and the reference group. The reference group was treated with TCM decoction. The combined group was given external TCM medicine more. Results: The total efficiency was 87.5% in the combined group, better than 62.5% in the reference group(P<0.05). The improvement of BASMI in the combined group was significantly better than the reference group, P<0.05. After treatment, the quality of life scores in two groups were improved, and the improvement in the combined group was better, P<0.05. Conclusion: TCM medicine was effective on ankylosing spondylitis, and is worthy of promotion.